LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Natural Beauty Bio-Technology Expects Wider Loss in H1 2024 MT
Natural Beauty Bio-Technology Limited Provides Earnings Guidance for the Year Six Months Ended 30 June 2024 CI
Natural Beauty Bio-Technology Appoints CEO MT
Natural Beauty Bio-Technology Limited Announces Appointment of Mr. Cheng Chi-Chung as Chief Executive Officer, effective July 16, 2024 CI
Natural Beauty Bio-Technology Limited Announces Resignation of Lin Yen-Ling as Chief Executive Officer, Effective 2 April 2024 CI
Natural Beauty Bio-Technology Limited Announces No Dividend for the Year Ended 31 December 2023 CI
Natural Beauty Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Natural Beauty Bio-Technology Limited Announces Appointment of Lin Yen-Ling as Executive Director and Member of Executive Committee CI
Natural Beauty Bio-Technology Limited Announces Management Changes, Effective January 1, 2024 CI
Natural Beauty Bio-Technology's H1 Loss Narrows MT
Natural Beauty Bio-Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Natural Beauty Bio-Technology Units Renew Contracts with Affiliates MT
Natural Beauty Bio-Technology Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Natural Beauty Bio-Technology to Swing to Loss in 2022 MT
Natural Beauty Bio-Technology Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022 CI
Natural Beauty Bio-Technology Limited Announces Director Changes, Effective January 1, 2023 CI
Natural Beauty Bio-Technology Swings to H1 Loss MT
Natural Beauty Bio-Technology Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Natural Beauty Bio-Technology Limited Announces Change of Company Secretary CI
Natural Beauty Bio-Technology Limited Announces Change of Address of Principal Place of Business in Hong Kong CI
Natural Beauty Bio-Technology Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022 CI
Natural Beauty Bio-Technology Expects to Swing to $3 Million Net Loss in H1 MT
Natural Beauty Bio-Technology Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2022 CI
Natural Beauty Bio-Technology Limited Announces Executive Changes CI
Natural Beauty Bio-Technology Limited Approves Final Dividend for the Year Ended 31 December 2021 CI
Chart Natural Beauty Bio-Technology Limited
More charts
Logo Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Ltd is an investment holding company mainly engaged in the manufacture and sale of beauty products. The Company is engaged in the manufacture and sale of a range of products, including skin care, beauty and aroma-therapeutic products, health supplements and make-up products and beauty apparatus. The Company distributes its products with domestic market and to overseas markets.
Employees
479
Calendar
More about the company

Annual profits - Rate of surprise